# EDGAR Filing Document

**Accession Number:** 0002081909
**File Stem:** 0000000000-25-009992
**Filing Date:** 2025-9
**Character Count:** 9408
**Document Hash:** 60a93b4838f268afcb3c6061550039d9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-009992.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0000000000-25-009992

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250916

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SilverBox Corp V
- **CENTRAL INDEX KEY:** 0002081909
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-289783

**BUSINESS ADDRESS:**
- **STREET 1:** 8701 BEE CAVE ROAD
- **STREET 2:** EAST BUILDING, SUITE 310
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78746
- **BUSINESS PHONE:** 5125753637

**MAIL ADDRESS:**
- **STREET 1:** 8701 BEE CAVE ROAD
- **STREET 2:** EAST BUILDING, SUITE 310
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78746
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001104659-25-081712

## Text-Extract

```

                                                            September 15, 2025

Stephen Kadenacy
Chief Executive Officer
SilverBox Corp V
8701 Bee Cave Road
East Building, Suite 310
Austin, TX 78746

       Re: SilverBox Corp V
           Registration Statement on Form S-1
           Filed August 19, 2025
           File No. 333-289783
Dear Stephen Kadenacy:

       We have reviewed your registration statement and have the following
comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Registration Statement on Form S-1
Cover Page

1.     Please revise your compensation disclosure to provide all the disclosure
required by
       Item 1602(a)(3) of Regulation S-K, including, for example,
cross-references,
       highlighted by prominent type or in another manner.
2.     Please expand your conflicts of interest disclosure in the paragraph
under the dilution
       table to address the conflicts between the SPAC, the sponsor, its
promoters and
       affiliates, on the one hand, and the public shareholders on the other.
Refer to Item
       1602(a)(4) of Regulation S-K.
Summary, page 1

3.     Please revise your compensation table on pages 4 and 99 to disclose the
anti-dilution
       adjustment of the founder shares to maintain the number of Class A
ordinary shares
 September 15, 2025
Page 2

       issuable upon conversion of the Class B ordinary shares at 20% of the
total number of
       ordinary shares outstanding and the cashless exercise of the private
placement
       warrants. Refer to Item 1602(b)(6) of Regulation S-K.
4.     In the compensation table on page 5, please expand to also discuss the
compensation
       payable to Messrs. Reece, Chun, and Esters, as your disclosures
elsewhere state that
       these individuals will receive some of the fees payable to SilverBox
Securities. See
       Items 1602(b)(6) and 1603(a)(6) of Regulation S-K.
5.     Please revise your transfer restrictions table on pages 6 and 101 to
disclose the
       underwriter's lock-up agreement. Refer to Item 1603(a)(9) of Regulation
S-K.
6.     In the fifth bullet point of your summary of risks on page 38, please
expand the risk
       factor to denote the percentage and amount of public shares that will be
needed to
       approve the initial business combination if shareholder approval is
sought (including
       if only a quorum voted) and similarly revise the corresponding risk
factor on page 45.
Risk Factors, page 44

7.     We note disclosure throughout your prospectus that your sponsor may
surrender or
       forfeit, transfer or exchange its securities, including for no
consideration. Please add
       risk factor disclosure about risks that may arise from the sponsor or a
sponsor affiliate
       having the ability to remove itself as your sponsor before identifying
an initial
       business combination, including through the unconditional ability to
transfer the
       founder shares or all or any portion of its membership interests in the
sponsor.
       Address the consequences of such removal to the company's ability to
consummate an
       initial business combination, including that any replacement sponsor
could have
       difficulty finding a target.
8.     With a view toward disclosure, please tell us whether your sponsor is,
is controlled
       by, has any members who are, or has substantial ties with, a non-U.S.
person. Also
       revise your filing to include risk factor disclosure that addresses how
this fact could
       impact your ability to complete your initial business combination. For
instance,
       discuss the risk to investors that you may not be able to complete an
initial business
       combination with a target company should the transaction be subject to
review by a
       U.S. government entity, such as the Committee on Foreign Investment in
the United
       States (CFIUS), or ultimately prohibited. Disclose that as a result, the
pool of potential
       targets with which you could complete an initial business combination
may be
       limited. Further, disclose that the time necessary for government review
of the
       transaction or a decision to prohibit the transaction could prevent you
from
       completing an initial business combination and require you to liquidate.
Disclose the
       consequences of liquidation to investors, such as the losses of the
investment
       opportunity in a target company, any price appreciation in the combined
company,
       and the warrants, which would expire worthless.
Use of Proceeds, page 85

9.     You state on page 87 and elsewhere that your initial shareholders,
officers and
       directors will agree to waive their rights to liquidating distributions
from the trust
       account with respect to any founder shares held by them if you fail to
complete your
       initial business combination. Please revise to clarify if they have also
waived such
 September 15, 2025
Page 3

       rights with respect to their private placement shares.
Dilution, page 89

10.    Please note that your disclosure starting on page 89 does not appear to
meet the
       requirements of Item 1602(c) of Regulation S-K. You may consider the
disclosures
       that you have made elsewhere in your filing such as on pages 39 to 41
       to enhance your dilution disclosure so that it will comply.
Proposed Business
Our Acquisition Process, page 106

11.    Please reconcile your disclosure here that there is no agreement,
arrangement, or
       understanding between your sponsor, you, and any of your officers and
directors with
       respect to determining whether to proceed with a business combination
with your
       disclosure elsewhere in the prospectus, including on pages 87 and 152,
that you will
       enter into a letter agreement with your initial shareholders, officers,
and directors in
       which they will agree to waive their redemption rights with respect to
the completion
       of an initial business combination and waive their redemption rights in
connection
       with a shareholder vote to approve the initial business combination, and
that they
       agree to vote any founder shares and any public shares in favor of your
initial business
       combination. Please also reconcile your disclosures, such as on page 45,
that these
       individuals have agreed to vote their founder shares, private placement
shares, and
       public shares, with disclosures, such as on page 117, that they have
agreed to vote
       their founder shares and public shares.
Certain Relationships and Related Party Transactions, page 146

12.    Please expand your disclosure regarding the financial services advisory
agreement
       between the company and SilverBox Securities filed as Exhibit 10.9 to
the registration
       statement to state the term of the engagement and the transaction fee to
be paid in the
       event of termination by the company, as outlined in Section 2 of the
agreement.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

        Please contact Howard Efron at 202-551-3439 or Shannon Menjivar at
202-551-3856
if you have questions regarding comments on the financial statements and
related
matters. Please contact Isabel Rivera at 202-551-3518 or Dorrie Yale at
202-551-8776 with
any other questions.

                                                                Sincerely,
 September 15, 2025
Page 4

                     Division of Corporation Finance
                     Office of Real Estate & Construction
cc:   Jonathan Ko

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._